Featured news

Musgrave Minerals (ASX: MGV) Board continues to unanimously recommen...

Highlights,Musgrave Minerals (ASX: MGV) has noted that Westgold Resources Limited’s offer has closed and lapsed.,MGV directors have accepted Ramelius’...

Know how EarlyBirds helps in tapping assistive technology solutions

Highlights,Open innovation ecosystems such as EarlyBirds play a significant role in levelling up the innovation game in assistive technologies.,EarlyB...

EarlyBirds helping universities build resources for new age workplac...

Highlights,While businesses are adopting new technology at a fast pace, it is essential that universities too match up their curriculum with the advan...

How EarlyBirds can help in cross-industry collaboration for driving...

Highlights,In the present state of the economy, cross-industry innovation has emerged as a strategic imperative for businesses.,EarlyBirds is facilita...

Mount Burgess (ASX: MTB) raising capital for metallurgical testwork...

Highlights,Mount Burgess is eyeing to raise AU$530,000 via a share placement at an issue price of AU$0.004 apiece.,Three directors of MTB have agreed...

QX Resources (ASX: QXR) share price jumps on Liberty lithium brine p...

Highlights,Due diligence and discussions have progressed on the western US-based Liberty lithium brine project.,Resampling of lithium brines in auger...

Surefire Resources (ASX: SRN) reports 4N HPA production from Victory...

Highlights,Test work using material from the Victory Bore project confirmed the production of 4N HPA, and the highest value achieved stood at 99.992%....

Radiopharm Theranostics (ASX: RAD) appoints highly experienced VP-Me...

Radiopharm Theranostics has appointed Dr Sherin Al-Safad as Vice President Medical and Corporate Affairs.

Mapping QX Resources’ (ASX: QXR) advances in battery minerals explor...

QX Resources marched through June 2023 quarter with a focus towards advancing its hard rock lithium project portfolio in Australia.,At the Turner Rive...

Cynata Therapeutics (ASX: CYP) gears up for clinical progress after...

Cynata Therapeutics has completed the strategic review of clinical development portfolio.

Imugene’s (ASX: IMU) HER - Vaxx and CHECKVacc to feature at ESMO Con...

Imugene (ASX: IMU) shared that its HER-Vaxx and CHECKVacc will be featured at ESMO Congress.

Bounty Oil & Gas (ASX: BUY) shares jump on PEP-11 update

Highlights,The Minister for Climate Change and Energy of Australia, Chris Bowen has designated an area of the Pacific Ocean area off the Hunter Region...

Black Canyon (ASX: BCA) advancing manganese exploration and HPMSM st...

Highlights,Black Canyon has received firm commitments to raise AU$1.95 million through a two-tranche share placement.,Strong support from existing sop...

Tempest Minerals (ASX: TEM) to acquire new base metal project in Ear...

Highlights,Tempest Minerals is acquiring the Five Wheels base metal project in a cash and scrip deal with MAC3 Pty Ltd.,The project located in the Ear...

Viking Mines (ASX: VKA) reports thick zones of massive magnetite at...

Highlights,Thick massive magnetite zones have been intersected at the Fold Nose target of the Canegrass Battery Minerals project.,Drilling at the Fold...

Imugene (ASX: IMU) announces research collaboration with RenovoRx fo...

Highlights,Imugene has formed a partnership with clinical-stage biopharmaceutical firm – RenovoRx for its oncolytic virus therapy.,The collaboration w...

Cooper Metals (ASX: CPM): Independent review defines new Cu-Au targe...

Highlights,Cooper Metals has revealed results for an independent consultant’s prospectivity review of Ardmore tenement.,The results have highlighted s...

Boab Metals (ASX: BML) crosses key milestone at Sorby Hills, secures...

Highlights,Boab Metals has executed a,Heads of Agreement with the Shire of Wyndham and East Kimberley (SWEK) to build a new accommodation facility wit...

Carbonxt (ASX: CG1) announces new board appointment to fuel US growt...

Highlights,Carbonxt has appointed Dr Imtiaz Kathawalla as a non-executive director.,Dr Kathawalla is expected to play a significant role in the develo...

Imugene (ASX: IMU) gets US patent for oncolytic virotherapy CF33, sh...

Highlights,Imugene has secured a patent for its licenced oncolytic virotherapy in the United States.,Oncolytic virotherapy CF33 comprises CHECKVacc an...